Actuate Therapeutics Inc (ACTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,134 | 13,159 | 16,925 | 6,493 | 3,889 |
| TOTAL | $8,519 | $13,643 | $17,444 | $6,689 | $4,249 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 392 | 393 | 270 | 280 | 235 |
| TOTAL | $392 | $393 | $270 | $280 | $235 |
| Total Assets | $8,911 | $14,036 | $17,714 | $6,969 | $4,483 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,201 | 1,524 | 1,245 | 3,171 | 2,644 |
| Accrued Expenses | 918 | 615 | 868 | 1,459 | 1,309 |
| TOTAL | $4,722 | $5,707 | $6,373 | $9,201 | $9,154 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 405 | 405 | 405 | 422 | 417 |
| TOTAL | $405 | $405 | $405 | $422 | $417 |
| Total Liabilities | $5,127 | $6,112 | $6,778 | $9,623 | $9,571 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,926 | 23,710 | 23,243 | 20,745 | 19,620 |
| Retained earnings | -160,233 | -154,608 | -150,054 | -144,646 | -138,697 |
| TOTAL | $3,784 | $7,924 | $10,936 | $-2,654 | $-5,088 |
| Total Liabilities And Equity | $8,911 | $14,036 | $17,714 | $6,969 | $4,483 |